Medication info
Candeletan 16 mg Tablets (Candesartan Cilexetil)

Candeletan 16 mg Tablets (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Pink, round tablets with a biconvex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201100298 · Approved 2011.01.20 · Insurance code 642904190

Summary

Main use
Treatment of essential hypertension and heart failure with impaired left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This drug should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure remains uncontrolled at this dose, another treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with reduced effective blood volume, administer an initial dose of 4 mg with careful caution. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience is limited in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with impaired left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • decreased left ventricular ejection fraction
View approved original text

This medicine is used to treat essential hypertension. It is also effective in patients with heart failure where the left ventricular ejection fraction is 40% or lower, and left ventricular systolic function is compromised. It is particularly helpful when additional effects are needed beyond ACE inhibitors or when ACE inhibitors are not well tolerated. Thus, it plays an important role in controlling blood pressure and improving heart function.

How to take

Adult dose

This drug should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure remains uncontrolled at this dose, another treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with reduced effective blood volume, administer an initial dose of 4 mg with careful caution. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience is limited in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Precautions

This drug can cause serious harm to the fetus and newborn if taken during pregnancy, especially during the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug, pregnant or nursing women, patients with severe liver impairment or cholestasis, patients with hereditary angioedema, patients with primary hyperaldosteronism, etc., should not take this medicine. Elderly patients, those with hyperkalemia, liver disease, valvular heart disease, ischemic heart disease, renal impairment, etc., should use this drug cautiously and monitor blood pressure and kidney function regularly. Side effects such as dizziness, back pain, respiratory infections may occur during use, and in rare cases, serious allergic reactions, deterioration of kidney function, and blood abnormalities may occur, so seek medical advice immediately if any abnormal symptoms appear. Since blood pressure may drop too low or kidney function may deteriorate, especially patients with heart failure or those taking diuretics should have regular blood pressure and blood tests. When used in combination with other antihypertensives or potassium supplements, diuretics, etc., the risk of side effects may increase, so consult with a physician before taking. Women who are pregnant or planning to become pregnant should not use this drug, and nursing mothers should also avoid taking it or discontinue breastfeeding. The safety of this drug in children and adolescents under 18 years of age has not been established, so its use is not recommended. Elderly patients are at risk of excessively low blood pressure, so special care is needed when taking this medication. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention is required. Keep this medicine out of reach of children, and it is safe not to transfer it to another container.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • weakness
  • fever
  • sensory disturbance
  • indigestion
  • gastroenteritis
  • tachycardia
  • palpitations
Show 66 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • nasal bleeding
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzymes
  • hepatitis
  • elevated AST
  • elevated ALT
  • increased γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container as it may deteriorate due to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink, round tablets with a biconvex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.